Learn about the breakthrough chronic lung disease discovery

Press/Media: Research

Description

Researchers at Queen’s University Belfast, Northern Ireland, have discovered a novel experimental treatment for chronic lung disease with the potential to improve lives.

For people with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), treatment is difficult, however, researchers have found that the symptoms associated with both diseases can be alleviated through inhibiting the activity of an enzyme found in those with chronic lung disease.

This builds on a previous study led by Queen’s University Belfast that discovered high levels of a particular enzyme, cathepsin S, in the lungs of children with CF and this was associated with increased inflammation and lung damage.

Period07 Mar 2019

Media coverage

1

Media coverage

  • TitleLearn about the breakthrough chronic lung disease discovery
    Media name/outletHealth Europa
    Country/TerritoryUnited Kingdom
    Date07/03/2019
    DescriptionResearchers at Queen’s University Belfast, Northern Ireland, have discovered a novel experimental treatment for chronic lung disease with the potential to improve lives.

    For people with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), treatment is difficult, however, researchers have found that the symptoms associated with both diseases can be alleviated through inhibiting the activity of an enzyme found in those with chronic lung disease.

    This builds on a previous study led by Queen’s University Belfast that discovered high levels of a particular enzyme, cathepsin S, in the lungs of children with CF and this was associated with increased inflammation and lung damage.
    URLhttps://www.healtheuropa.eu/chronic-lung-disease/90663/
    PersonsDonna Small